KOMISJA NADZORU FINANSOWEGO | |||||||||||
Raport bieżący nr | 2 | / | 2019 | ||||||||
Data sporządzenia: | 2019-08-23 | ||||||||||
Skrócona nazwa emitenta | |||||||||||
MILESTONE MEDICAL | |||||||||||
Temat | |||||||||||
Information on the date of the Annual Meeting of Shareholders | |||||||||||
Podstawa prawna | |||||||||||
Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bieżące i okresowe | |||||||||||
Treść raportu: | |||||||||||
The Board of Directors of Milestone Medical, Inc. (“Company”) informs that the Annual Meeting of Shareholders of the Company shall be held on Wednesday, October 3, 2019 in Livingston, New Jersey, United States of America at the corporate office of Milestone Scientific Inc., located at. 220 South Orange Avenue, Suite 102 at 9:00 am. The record date for the notice of the meeting and the record date for voting, as well as the date of the determination of beneficial ownership shall be August 21, 2019. Further information concerning the Meeting will be given by the Issuer by way of subsequent current reports and at the Company's website. | |||||||||||
Załączniki | |||||||||||
Plik | Opis | ||||||||||
MMD draft of resolutions 2019.pdf | Draft of Resolutions Annual Shareholders Meeting | ||||||||||
MMD Proxy Card 2019.pdf | Proxy Card Annual Shareholders Meeting |
MESSAGE (ENGLISH VERSION) | |||
MILESTONE MEDICAL INC | |||||||||||||
(pełna nazwa emitenta) | |||||||||||||
MILESTONE MEDICAL | |||||||||||||
(skrócona nazwa emitenta) | (sektor wg. klasyfikacji GPW w W-wie) | ||||||||||||
NJ 07039 | . | ||||||||||||
(kod pocztowy) | (miejscowość) | ||||||||||||
South Orange Avenue Livingston | 220 | ||||||||||||
(ulica) | (numer) | ||||||||||||
+11 973 535 2717 | +11 973 535 2829 | ||||||||||||
(telefon) | (fax) | ||||||||||||
(e-mail) | (www) | ||||||||||||
27-5484393 | |||||||||||||
(NIP) | (REGON) | ||||||||||||
PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
2019-08-23 | Joseph D'Agostino | Chief Financial Officer | Joseph D'Agostino |